SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-011886
Filing Date
2020-08-06
Accepted
2020-08-06 07:10:15
Documents
16
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq22020pressrelease.htm   iXBRL 8-K 51758
2 EXHIBIT 99.1 ex-991earningsreleaseq.htm EX-99.1 193820
8 CERECOR LOGO cerecorlogoa68.jpg GRAPHIC 16081
  Complete submission text file 0001628280-20-011886.txt   422113

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20200806.xsd EX-101.SCH 4467
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20200806_cal.xml EX-101.CAL 642
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20200806_def.xml EX-101.DEF 1492
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20200806_lab.xml EX-101.LAB 26189
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20200806_pre.xml EX-101.PRE 13610
9 EXTRACTED XBRL INSTANCE DOCUMENT a8-kq22020pressrelease_htm.xml XML 4328
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 201079770
SIC: 2834 Pharmaceutical Preparations